跳至主要内容
临床试验/IRCT2014120520216N1
IRCT2014120520216N1已完成2 期

Effects of treatment with vitamin D3 in Hashimoto's Thyroiditis with vitamin D deficiency on Thyroid function, antithyroid antibodies and metabolic markers

Vice Chancellor for research, Isfahan University of Medical Science0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 60 years(—)
性别
All

入选标准

  • age 20 to 60 years;
  • anti thyroid peroxidase antibody positive;
  • serum 25 hydroxyl vitamin D 3 is less than 20 nanogram per milliliter;
  • euthyroid or hypothyroid;
  • if Levothyroxin or other metabolic drugs like Statins, Metformin consumed, starting time was more than 6 months ago.
  • Exclusion criteria:
  • immunosuppressor drugs intake before the study;
  • dietary supplementation intake per oral or injections before study;
  • comorbid disease ;
  • severe weight loss;
  • insulin taking.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for research, Isfahan University of Medical Science

相似试验